Dr. Reddy's Laboratories has joined the Science Based Targets initiative's (SBTi) business ambition for 1.5 c, becoming the first Indian and the third Asian pharmaceutical company to have set its Science-Based
Targets to further minimize environmental impact.
The Company has committed to reducing its Scope 1 and 2 greenhouse gas (GHG) emissions by 55 percent by 2030 from a FY2017-18 base year, which are in line with the latest climate science of limiting global warming to below 1.5 c above pre-industrial levels.
As of FY 2019-20, Dr. Reddy's has reduced its Scope 1 emissions by 8.6% and Scope 2 emissions by 20.7% over the baseline of FY 2017-18. The combined Scope 1 and 2 emissions have been reduced by 13% over the same base year, putting it on a fast track to achieving GHG reduction targets.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
